Gunasekaran H, Ranganathan U, Bethunaickan R
Front Immunol. 2025; 16:1538127.
PMID: 39981231
PMC: 11839662.
DOI: 10.3389/fimmu.2025.1538127.
Peters J, Irvine E, Makatsa M, Rosenberg J, Wadsworth 2nd M, Hughes T
Sci Adv. 2025; 11(1):eadq8229.
PMID: 39742484
PMC: 11694782.
DOI: 10.1126/sciadv.adq8229.
Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L
Exploration (Beijing). 2024; 4(5):20230138.
PMID: 39439490
PMC: 11491313.
DOI: 10.1002/EXP.20230138.
Agarwal M, Bhaskar A, Singha B, Mukhopadhyay S, Pahuja I, Singh A
Commun Biol. 2024; 7(1):949.
PMID: 39107377
PMC: 11303689.
DOI: 10.1038/s42003-024-06620-9.
Montero-Vega M, Matilla J, Bazan E, Reimers D, De Andres-Martin A, Gonzalo-Gobernado R
Cells. 2024; 13(6.
PMID: 38534380
PMC: 10969755.
DOI: 10.3390/cells13060536.
The multivalency game ruling the biology of immunity.
Aiassa L, Battaglia G, Rizzello L
Biophys Rev (Melville). 2024; 4(4):041306.
PMID: 38505426
PMC: 10914136.
DOI: 10.1063/5.0166165.
The Interplay between and Human Microbiome.
Nguyen M, Ahn P, Dawi J, Gargaloyan A, Kiriaki A, Shou T
Clin Pract. 2024; 14(1):198-213.
PMID: 38391403
PMC: 10887847.
DOI: 10.3390/clinpract14010017.
Nuclear Factor κB Signaling Deficiency in CD11c-Expressing Phagocytes Mediates Early Inflammatory Responses and Enhances Mycobacterium tuberculosis Control.
Chauhan K, Dunlap M, Akter S, Gupta A, Ahmed M, Rosa B
J Infect Dis. 2024; 230(2):336-345.
PMID: 38324907
PMC: 11326832.
DOI: 10.1093/infdis/jiae060.
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis.
Weeratunga P, Moller D, Ho L
J Clin Invest. 2024; 134(1).
PMID: 38165044
PMC: 10760966.
DOI: 10.1172/JCI175264.
From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning.
Li L, Yang L, Zhuang L, Ye Z, Zhao W, Gong W
Mil Med Res. 2023; 10(1):58.
PMID: 38017571
PMC: 10685516.
DOI: 10.1186/s40779-023-00490-8.
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.
Nair A, Greeny A, Nandan A, Sah R, Jose A, Dyawanapelly S
J Nanobiotechnology. 2023; 21(1):414.
PMID: 37946240
PMC: 10634178.
DOI: 10.1186/s12951-023-02156-y.
The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth.
Nore K, Louet C, Bugge M, Gidon A, Jorgensen M, Jenum S
J Infect Dis. 2023; 229(3):888-897.
PMID: 37721470
PMC: 10938220.
DOI: 10.1093/infdis/jiad390.
Initial immune response after exposure to or to SARS-COV-2: similarities and differences.
Aiello A, Najafi-Fard S, Goletti D
Front Immunol. 2023; 14:1244556.
PMID: 37662901
PMC: 10470049.
DOI: 10.3389/fimmu.2023.1244556.
cGAS-STING Pathway Activation during Trypanosoma cruzi Infection Leads to Tissue-Dependent Parasite Control.
Perumal N, White B, Sanchez-Valdez F, Tarleton R
J Immunol. 2023; 211(7):1123-1133.
PMID: 37603014
PMC: 10783805.
DOI: 10.4049/jimmunol.2300373.
NCoR1 controls Mycobacterium tuberculosis growth in myeloid cells by regulating the AMPK-mTOR-TFEB axis.
Biswas V, Sen K, Ahad A, Ghosh A, Verma S, Pati R
PLoS Biol. 2023; 21(8):e3002231.
PMID: 37590294
PMC: 10465006.
DOI: 10.1371/journal.pbio.3002231.
Investigating Mycobacterium tuberculosis sufR (rv1460) in vitro and ex vivo expression and immunogenicity.
Baatjies L, van Rensberg I, Snyders C, Gutschmidt A, Loxton A, Williams M
PLoS One. 2023; 18(6):e0286965.
PMID: 37319185
PMC: 10270350.
DOI: 10.1371/journal.pone.0286965.
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis.
Grifoni A, Alonzi T, Alter G, Noonan D, Landay A, Albini A
Front Immunol. 2023; 14:1146704.
PMID: 37292210
PMC: 10246744.
DOI: 10.3389/fimmu.2023.1146704.
Clinical manifestations and immune response to tuberculosis.
Carabali-Isajar M, Rodriguez-Bejarano O, Amado T, Patarroyo M, Izquierdo M, Lutz J
World J Microbiol Biotechnol. 2023; 39(8):206.
PMID: 37221438
PMC: 10205569.
DOI: 10.1007/s11274-023-03636-x.
Pathologic characteristics of infectious diseases in macaque monkeys used in biomedical and toxicologic studies.
Ohta E
J Toxicol Pathol. 2023; 36(2):95-122.
PMID: 37101957
PMC: 10123295.
DOI: 10.1293/tox.2022-0089.
Dual oxidase 1 is dispensable during infection in mice.
Gupta T, Sarr D, Fantone K, Ashtiwi N, Sakamoto K, Quinn F
Front Immunol. 2023; 14:1044703.
PMID: 36936954
PMC: 10020924.
DOI: 10.3389/fimmu.2023.1044703.